Selected article for: "influenza virus and vaccine development"

Author: Chiramel, Abhilash I.; Brady, Nathan R.; Bartenschlager, Ralf
Title: Divergent Roles of Autophagy in Virus Infection
  • Document date: 2013_1_25
  • ID: 1oawya1p_31
    Snippet: A number of studies have convincingly demonstrated that autophagy can influence the presentation of viral antigens on MHC-I and MHC-II [66] . Studies with HSV-1 showed that at early time points after infection, autophagy is not required for viral antigen processing and presentation of MHC-I peptides, but comes into play at late stage of infection [67] . However, it remains unknown how degradation of HSV-1 particles by the autophagosome results in.....
    Document: A number of studies have convincingly demonstrated that autophagy can influence the presentation of viral antigens on MHC-I and MHC-II [66] . Studies with HSV-1 showed that at early time points after infection, autophagy is not required for viral antigen processing and presentation of MHC-I peptides, but comes into play at late stage of infection [67] . However, it remains unknown how degradation of HSV-1 particles by the autophagosome results in the presentation of viral antigens to ER localized MHC-I molecules. In the case of Epstein Barr virus (EBV), the viral protein EBNA1 is targeted to MHC-II compartments via autophagic uptake and fusion of autophagosomes with these compartments [68] . Inhibition of autolysosomal acidification resulted in enrichment of EBNA1-positive autophagosomes, and knock-down of Atg12 rendered the cells unable to stimulate MHC-II-dependent activation of T-cells [69] . Importantly, already under normal conditions and in the absence of viral infection, autophagy was required for the consecutive delivery of antigens to MHC-II molecules, arguing for a crucial role of autophagy in MHC-II presentation of antigens in vivo [70] . Furthermore, by fusing the matrix protein of influenza virus to LC3, an increased MHC-II activation of CD4+ T-cells was observed, thus revealing an unexplored strategy for vaccine development [70] .

    Search related documents:
    Co phrase search for related documents
    • antigen MHC II presentation and MHC peptide: 1
    • antigen MHC II presentation and vaccine development: 1
    • antigen MHC II presentation and viral antigen: 1, 2, 3
    • antigen MHC II presentation and viral antigen presentation: 1, 2
    • antigen MHC II presentation and viral infection: 1, 2
    • antigen MHC II presentation and viral protein: 1, 2
    • antigen processing and crucial role: 1, 2, 3, 4
    • antigen processing and influenza virus: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • antigen processing and MHC II presentation: 1, 2, 3, 4
    • antigen processing and MHC molecule: 1, 2
    • antigen processing and MHC peptide: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
    • antigen processing and presentation viral antigen processing: 1, 2, 3, 4, 5, 6
    • antigen processing and study number: 1, 2
    • antigen processing and vaccine development: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18
    • antigen processing and viral antigen: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • antigen processing and viral antigen presentation: 1, 2, 3, 4, 5, 6, 7
    • antigen processing and viral antigen processing: 1, 2, 3, 4, 5, 6, 7, 8
    • antigen processing and viral infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • antigen processing and viral protein: 1, 2, 3, 4, 5, 6